RoundUp Lawsuit – December 2024 Update

Individuals are filing RoundUp lawsuits against Monsanto (now Bayer) because of the increased risk of certain kinds of cancer, including non-Hodgkin’s lymphoma and multiple myeloma, associated with exposure to the weed killer’s main ingredient. These lawsuits have been consolidated into MDL# 2741 – In re: Roundup Products Liability Litigation in the Northern District of California. As of December 2024, there are 4,355 lawsuits pending in the federal RoundUp litigation. The presiding judge is Vince Chhabria. This lawsuit is in the mid-stages, with the discovery phase ongoing. People are continuing to file RoundUp lawsuits today.

RoundUp Lawsuit Timeline & News – December 2024

November 26, 2024: Judge Asked to Approve Settlement in Two Roundup Lawsuits

U.S. District Court Judge Vince Chhabria was asked to approve settlements in two Roundup cases pending in the MDL. The plaintiffs each died from cancer, which, according to legal documents, was caused by their exposure to the weed killer. If accepted, the settlements will likely be kept confidential. 

November 18, 2024: Jury Finds for Monsanto (Bayer) in the Womack Case

A jury out of the Philadelphia Court of Common Pleas reached a verdict in favor of Monsanto. According to a statement released by Bayer, which acquired Monsanto in 2018, said the decision in the Womack case marked the third victory for them out of the Court of Common Pleas. 

November 15, 2024: Multiple Lawsuits Dismissed from Roundup MDL Signaling Potential Settlements

Several lawsuits have been dismissed in the Roundup MDL, potentially indicating settlements were reached. In 2020, Bayer agreed to pay out nearly $11 billion to settle almost 100,000 claims. Despite this large settlement, several thousand cases remain pending, including over 4,000 in the Roundup MDL.  

November 5, 2024: Total Pending Case Number in Roundup MDL Up to 4,355

As reported by the Judicial Panel on Multidistrict Litigation, the number of total pending lawsuits in the Roundup MDL out of the Northern District of California has grown to 4,355. The total number of cases in the MDL to date has been 4,962 with some cases being dismissed either due to settlement, by request, or because of procedural problems.

October 15, 2024: Bayer Ordered to Pay $78 Million in State Roundup Cancer Trial

Bayer, who acquired Monsanto in 2018, has been ordered to pay $78 million in a Roundup cancer trial. A Philadelphia jury awarded a man who had developed non-Hodgkin’s lymphoma after using the weedkiller $3 million in compensatory damages and $75 million in punitive damages.

What is the RoundUp Lawsuit About?

For decades, scientists have warned about the potential harmful effects of glyphosate, the active ingredient in RoundUp. Studies show exposure to the chemical can significantly increase a person’s risk of developing certain kinds of cancer, including non-Hodgkin’s lymphoma. 

Despite these concerns, RoundUp has become one of the most widely used weed killers in the nation. Lawsuits allege that the manufacturer of RoundUp, Monsanto (now Bayer), knew or should have known about these dangers and failed to warn consumers. 

Allegations also include the company downplaying the risks, attempting to mislead consumers and regulatory agencies about the safety of their product, and putting countless people in harm’s way.

RoundUp Lawsuit Information
Lawsuit Name:	In re: Roundup Products Liability Litigation
Main Injuries:	Non-Hodgkin’s Lymphoma, Multiple Myeloma, Hairy Cell Leukemia, and other kinds of Cancer
Defendants:	Monsanto (now Bayer)
Mass tort or class action?	Mass Tort
MDL Number:	2741
Pending Cases:	4,355
Court Name (Venue):	Northern District of California
Have There Been Settlements?	Yes
Active Lawsuit?	Yes

Why Are People Filing RoundUp Lawsuits?

Individuals nationwide are filing lawsuits against Bayer AG, a German pharmaceutical company, alleging that the company knew or should have known that their product, RoundUp, contained a potentially cancer-causing ingredient. Bayer began manufacturing the popular pesticide in 2018 after acquiring Monsanto. 

It is alleged that exposure to glyphosate, the active ingredient in RoundUp, may increase a person’s risk of developing certain kinds of cancer, including non-Hodgkin’s lymphoma. Over 100,000 claims have been filed nationwide accusing Monsanto (now Bayer) of manufacturing and marketing a dangerous and defective product. Due to the widespread use of the weedkiller, it is expected that millions of people may have been exposed over the last several decades.

RoundUp Lawsuit Spotlight

McKivison v. Monsanto, Co.

According to court documents, John McKivison was diagnosed with non-Hodgkin’s lymphoma after using Roundup for two decades. The 49-year-old Pennsylvania man alleged that the weed killer was the cause of his injuries. Monsanto, the manufacturer, was awarded $2.25 billion by a jury in the Philadelphia Court of Common Pleas. 

The award was later reduced to $400 million, which both parties said they would appeal. Despite this reduction, the award still marks an important victory for plaintiffs in Roundup litigation. 

Whom Are People RoundUp Lawsuits Against?

Roundup lawsuits are generally filed against Monsanto Co., the original manufacturer of the weedkiller. However, Monsanto was acquired by Bayer AG on June 7, 2018 for $63 billion, including debt.  

Lawsuits against Monsanto (now Bayer) allege that the company knew or should have known about the risks associated with the use of the weed killer and failed to warn consumers. Additionally, litigation alleges the company downplayed the risks of the pesticide, exposing countless people to harm.

Defendant: Monsanto

Monsanto was originally founded as Monsanto Chemical Works in 1901 by John F. Queeny. The company began manufacturing glyphosate-based weed killers in the 1970s. Roundup became increasingly popular due to its effectiveness.

By the mid-1980s, however, a growing number of researchers were voicing concerns over the effect the pesticide had on humans and the environment. Despite these concerns, Monsanto continued manufacturing the weedkiller until 2018, when the company was acquired by Bayer AG. Since that time, Bayer has been the primary marketer and manufacturer of the pesticide.

Allegations Against Monsanto and Bayer

Allegations against Monsanto and Bayer include the fact that the companies manufactured a dangerous and defective product and were negligent. Additionally, complaints accuse the manufacturers of engaging in deceptive marketing, including downplaying the risks associated with exposure to the pesticide. 

Plaintiffs also say that the manufacturers knew or should have known about the risks associated with exposure to glyphosate, the active ingredient in Roundup, and failed to warn consumers. The failure to warn resulted in countless people being exposed to the substance and put at an increased risk for developing certain kinds of cancer, such as non-Hodgkin’s lymphoma.

What Stage is the RoundUp Lawsuit In?

In total, over 100,000 claims have been filed against Monsanto and Bayer in state and federal courts. Over 4,300 lawsuits remain in a federal MDL pending out of the Northern District of California. In 2020, Bayer paid nearly $11 billion to settle approximately 75% of the pending cases. 

Despite these settlements, individuals who were diagnosed with non-Hodgkin’s lymphoma after being exposed to Roundup are encouraged to seek legal recourse. While these lawsuits are moving quickly, there is still time to file.

What Is RoundUp and How Does It Work?

RoundUp is one of the most popular pesticides in the world. It was originally manufactured and marketed by Monsanto before the company was acquired by Bayer in 2018. 

The weedkiller contains glyphosate, a non-selective herbicide that is absorbed through the leaves and distributed throughout the plant. It works by preventing the roots from absorbing the nutrients necessary for growth, eventually leading to the death of the plant. 

The weedkiller was used in both commercial and residential settings for decades. It is unable to differentiate between weeds and other plants, meaning that even valuable plants may be lost in the process. 

When applied to plants, glyphosate can cause:

• Stunted growth
• Leaf discoloration
• Malformation
• Death of the plant

Roundup, containing glyphosate, is available in a number of formulations, including liquid concentrate and ready-to-use sprays. Approximately 280 million pounds are applied annually across the country. It can prevent new weeds from growing for up to four months and becomes rainproof within 30 minutes. 

While an effective herbicide, glyphosate exposure has been linked to an increased risk of cancer, including non-Hodgkin’s lymphoma. Over 100,000 claims have been filed against Monsanto and Bayer, alleging the companies knew or should have known about this risk and failed to warn consumers.

Active Ingredients in RoundUp

The primary active ingredient in RoundUp is glyphosate. According to the Environmental Protection Agency (EPA), glyphosate was first registered as a pesticide in the U.S. in the mid-1970s. The chemical is an effective weed killer with known ecological risks.

In addition to glyphosate, RoundUp also contains:

• Isopropylamine Salt: Odorless and crystalline, used to enhance the effect of glyphosate.
• Polyethoxylated Tallow Amine (POEA): Surfactant used to maximize coverage and enhance leaf penetration. Studies show the substance is toxic to aquatic life. Since Roundup with POEA is considered more harmful to fish and amphibians, it is not included in aquatic formations.
• Diquat Dibromide and Pelargonic Acid: Help to break down the cells of the plant, accelerating death. 
• Water

There are several different products under the Roundup brand that contain different formulations of glyphosate and have varying concentrations of other ingredients, such as POEA. There are also non-glyphosate formulations for use in lawns and other non-commercial places. Safety concerns have been raised over the varying ingredients and glyphosate in RoundUp with calls for additional regulatory oversight.

RoundUp Product Overview and History

Glyphosate, the active ingredient in RoundUp, was introduced in 1973 and patented by Monsanto. The U.S. patent on glyphosate expired in 2000, allowing more products with differing variations to flood the market with the potentially dangerous substance. Today, glyphosate is the most widely used herbicide in American agriculture. The rights to RoundUp are now owned by Bayer due to its acquisition of Monsanto in 2018.

How Do People Use RoundUp?

RoundUp is a widely-used herbicide in the U.S. It is used in both residential and agricultural settings and applied to a number of crops, including fruits and vegetables. The pesticide is available in several forms, such as liquid concentrate and ready-to-use sprays. However, due to its non-selective nature, drift can often cause harm to nearby untargeted plants.

The weedkiller is known for its efficacy and can begin to work within hours of application. Although, it can take several weeks for the death of the plant to occur. It works best when it is applied to plants in an active growth phase and requires precise application to ensure non-targeted plants are not damaged. 

How Does RoundUp Exposure Affect Human Health?

According to multiple studies, regulatory agencies, and prior lawsuits, RoundUp exposure can directly affect human health and negatively impact the environment. 

Research indicates that it can directly affect the cell development of animals and has neurotoxic effects. Other health effects include irritation, rash, vomiting, and diarrhea. In March 2015, the International Agency for Research on Cancer, a part of the World Health Organization, classified glyphosate as a probable human carcinogen, meaning it may cause cancer in humans.  

Symptoms of Short-term, Intense Roundup Exposure 

Long-Term Complications Associated With RoundUp Exposure

Cancers and Health Issues Related to RoundUp

Glyphosate, the active ingredient in RoundUp, has been linked to an increased risk of certain kinds of cancers, including non-Hodgkin’s lymphoma, multiple myeloma, and other lymphatic cancers. Exposure to the widely-used herbicide has also been linked to concerning health conditions such as neurological disorders and chronic diseases. 

A study from the Department of Environmental & Occupational Health Sciences (DEOHS) at the University of Washington found that exposure to glyphosate increases the risk of non-Hodgkin lymphoma by 41%. Research published by the American Association for Cancer Research also found that glyphosate is an environmental risk factor for multiple myeloma.

Cancers associated with glyphosate exposure:

Other health concerns linked to RoundUp exposure:

Individuals in high-risk groups, such as landscapers and farmers, are strongly encouraged to engage in regular health check-ups and seek legal advice for any adverse diagnosis potentially related to their RoundUp exposure. 

Due to the potential delay in the onset of symptoms, affected individuals should seek legal counsel immediately. Allegations against the manufacturer of RoundUp, Monsanto (now Bayer), include that they knew about the increased risk of cancer associated with glyphosate exposure and failed to warn consumers. This could lead to significant legal challenges and settlements. 

Non-Hodgkin Lymphoma (NHL)

Evidence from established studies and regulatory agencies has led to thousands of lawsuits being filed across the nation alleging that Roundup exposure resulted in the development of non-Hodgkin lymphoma. Analysis from the UW Department of Environmental & Occupational Health Sciences (DEOHS) found glyphosate exposure presents a 41% increased risk of non-Hodgkin’s lymphoma. 

Additionally, the International Agency for Research on Cancer classified pure glyphosate and glyphosate-based formulations as “probably carcinogenic to humans.” In particular, the agency found a “statistically significant association” between glyphosate exposure and the development of non-Hodgkin lymphoma.  

Risk factors for Roundup-related Non-Hodgkin Lymphoma:

• Higher and Prolonged Exposure: The duration and intensity of glyphosate exposure can increase a person’s risk of developing non-Hodgkin’s lymphoma. 

Individuals in high-risk occupations, such as landscapers, agricultural workers, and farmers, should be aware of potential non-Hodgkin lymphoma (NHL) symptoms. Any new or worsening health conditions, particularly persistent flu-like symptoms that last for two weeks or more, should be immediately reported to a healthcare provider. Prompt diagnosis and treatment are often critical to a successful outcome.

Symptoms of NHL:

Outcomes for People with NHL

Treatments for people with NHL include chemotherapy, radiation, immunotherapy, and surgery. 

According to the American Cancer Society, the 5-year relative survival rate for non-Hodgkin lymphoma is 74%, meaning that approximately 74% of people diagnosed with NHL are still alive after five years. However, the survival rate depends on several factors, including the type and stage of cancer, treatment options, and the age of the individual. 

Multiple Myeloma

Multiple myeloma is a blood cancer that has been associated with glyphosate exposure. Findings published by the American Association for Cancer Research determined that glyphosate exposure was an environmental risk for non-Hodgkin lymphoma and multiple myeloma. Specifically, the researchers found a B-cell-specific mutational mechanism for exposure to glyphosate that can increase the risk for multiple myeloma and non-Hodgkin lymphoma.

The genotoxic effects of glyphosate exposure have been linked with immunosuppression, disruption of the endocrine system, and genetic alterations. They have also been connected to oxidative stress, a key indicator in the development of cancer, including multiple myeloma.

Outcomes for People with Multiple Myeloma

Long-term or a longer duration of exposure to glyphosate has been linked with an increased risk of multiple myeloma and other kinds of cancer. Multiple myeloma can be slow-growing but generally necessitates treatment. Treatment includes radiation, chemotherapy, a bone marrow transplant, and targeted therapy. Complications from multiple myeloma may be serious and potentially life-threatening; these include bone pain, bone loss, anemia infections, and kidney damage.

Diffuse Large B-cell Lymphoma

Diffuse Large B-cell lymphoma (DLBCL) is a fast-growing type of non-Hodgkin lymphoma. It involves the uncontrolled growth of white blood cells or lymphocytes. Several subtypes of B-cell lymphoma have been linked to exposure to glyphosate. While it can grow quickly, DLBCL is highly treatable if caught early. 

Signs and Symptoms of DLBCL:

Studies indicate that glyphosate exposure may cause DNA mutations in white blood cells, potentially increasing a person’s risk of developing DLBCL. RoundUp formulations using surfactants may enhance glyphosate’s ability to permeate the skin, increasing the likelihood of toxic exposure. Individuals applying glyphosate without the proper protective gear are at a higher risk of harm. 

Outcomes for People With DLBCL

Individuals experiencing consistent flu-like symptoms for two weeks or more after exposure to Roundup are encouraged to contact their healthcare provider. Early detection is often key to a successful outcome.

The cost of treating DLBCL can be substantial. It may require chemotherapy, a stem cell transplant, or CAR-T Cell therapy. 

Multiple lawsuits allege that the manufacturer of Roundup knew about the risk of cancer development associated with glyphosate exposure and failed to warn consumers. An attorney can help determine whether you may be eligible for compensation related to your cancer diagnosis and treatment. 

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia (CLL) is a blood and bone marrow cancer affecting white blood cells known as lymphocytes. It is primarily found in adults and is a slow-progressing type of non-Hodgkin lymphoma.

Several studies have shown that glyphosate, the main ingredient in Roundup, may be carcinogenic. This means that it could cause cancer in humans. Prolonged exposure may increase a person’s chances of developing certain kinds of cancer, including chronic lymphocytic leukemia. 

Signs and Symptoms of Chronic Lymphocytic Leukemia:

Individuals in high-risk occupations, such as landscapers, gardeners, and farmers, may be at an increased risk of developing CLL due to their long-term exposure. The cancer is usually diagnosed through a blood test and may require chemotherapy to treat. 

Outcomes for People With CLL

While CLL may not require immediate treatment in its early stages, the medical costs can increase over time. Depending on the diagnosis, individuals may have to go through chemotherapy, targeted therapy, radiation, or immunotherapy to treat. 

Individuals working with Roundup or other pesticides are encouraged to engage in regular healthcare screenings to ensure early detection and treatment of the cancer. 

Signs and Symptoms of Long-Term RoundUp Exposure

Long-term exposure to Roundup has been associated with a number of adverse health events, including an increased risk of certain kinds of cancers. Studies show glyphosate, the active ingredient in the herbicide, may increase a person’s risk of developing non-Hodgkin’s lymphoma by up to 41%. 

Signs and Symptoms of Long-term Exposure to Glyphosate:

Individuals working with the weedkiller should seek immediate medical attention if they experience flu-like symptoms lasting for more than two weeks. 

Scientific Studies Linking RoundUp to Non-Hodgkin’s Lymphoma

In 2019, researchers from the University of Washington and the University of California-Berkeley found that individuals exposed to glyphosate-based herbicides were at a 41% increased risk of developing non-Hodgkin lymphoma. This and other research suggest that the International Agency for Research on Cancer’s classification of glyphosate as “probably carcinogenic to humans” should be confirmed. 

Studies linking glyphosate to non-Hodgkin lymphoma:

• 2019 UW and UC Study: The meta-analysis found a “compelling link” between exposure to glyphosate-based herbicides and an increased risk of developing non-Hodgkin lymphoma (NHL). The risk for NHL was increased by 41%.
• Journal of the National Cancer Institute: Found an association between the exposure of glyphosate and urinary oxidative stress biomarkers in humans. Oxidative stress markers are a key component in the development of cancer.
• Clinical Lymphoma, Myeloma, & Leukemia: Reviewed and confirmed 2019 findings that glyphosate and glyphosate-based formulations increased a person’s risk of developing non-Hodgkin lymphoma.

Important Study: Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: A meta-analysis and supporting evidence

In 2019, researchers from UC Berkeley and the University of Washington sought to investigate whether there was an association between exposure to glyphosate-based herbicides and an increased risk of non-Hodgkin lymphoma in humans. Conducting a meta-analysis of the data in the 2018 Agricultural Health Study (AHS) along with five case-control studies, the researchers determined that there was a 41% increased risk for NHL with high cumulative exposure to glyphosate-based herbicides.

Overview: Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: A meta-analysis and supporting evidence
Description of Study:	A meta-analysis investigating the potential link between exposure to glyphosate-based herbicides and increased risk for non-Hodgkin lymphoma.
Published In:	Mutation Research/Reviews in Mutation Research
Study Authors	Luoping Zhang, Iemaan Rana, Rachel M. Shaffer, Emanuela Taioli, Lianne Sheppard
Type of Study	Meta-analysis of 2018 Agricultural Health Study (AHS)
Findings	The researchers concluded that there was a 41% increased risk for non-Hodgkin lymphoma with exposure to glyphosate-based herbicides.

Did Monsanto Know About the Dangers of RoundUp?

Legal documents filed across the nation alleged that Monsanto knew the dangers associated with glyphosate and failed to warn consumers. The company is accused of concealing documents containing evidence of the potentially carcinogenic effects of glyphosate, Roundup’s main ingredient, to avoid massive recalls and liability. 

Evidence indicating Monsanto knew about the dangers of Roundup:

• 1983 Bio/dynamics Laboratory Study: The study conducted by Monsanto to study the carcinogenic effects of glyphosate exposure on mice found a potential link. Despite their own study indicating a possible connection between the herbicide and cancer, Monsanto has routinely promoted the product’s safety.
  
• “The Monsanto Papers”: The collection of papers, including internal communications from the company, show a comprehensive attempt to downplay the dangers of glyphosate despite knowing the risk and controlling the narrative. The papers also indicate the manufacturer’s influence over the regulatory process. The documents span over the course of several decades.

In 2015, the International Agency for Research on Cancer labeled glyphosate as “probably carcinogenic.” Monsanto went to extreme lengths to contest these findings, building a campaign to try and counter the messaging. Despite concerning evidence that points to the dangers of glyphosate exposure, the company continued marketing the product as a safe herbicide.

Evidence presented at prior trials also shows that the company ghostwrote studies that appeared to be independent and misrepresented information to the public. Allegations also include that Monsanto interfered through lobbying efforts to manipulate findings from the Environmental Protection Agency to avoid having the weedkiller listed as a probable carcinogen.

EPA Warnings About RoundUp

The Environmental Protection Agency (EPA) has repeatedly said that glyphosate is “not likely to be carcinogenic to humans” despite research to the contrary.  It is believed that Monsanto may have influenced the regulatory agency’s findings through lobbying efforts and ghostwritten studies that appear to be independent. The EPA has said that the herbicide has potential ecological risks. 

Other regulatory agencies, such as the World Health Organization and the California Office of Environmental Health Hazard Assessment, have listed glyphosate as a probable human carcinogen. 

What Damages Can People Sue RoundUp Manufacturers For?

Roundup manufacturers may be liable for a number of damages, including past and future medical bills, lost wages, and pain and suffering. Depending on the situation, claimants may also be able to sue for punitive damages, which are designed to hold the manufacturer accountable for gross negligence or intentional misconduct. 

Damages in a RoundUp lawsuit may include:

• Medical Bills: Individuals in a Roundup lawsuit may be entitled to damage related to their medical bills, such as compensation for their doctor’s visits, chemotherapy, radiation, and other medical interventions.
  
• Lost Wages: If the cancer resulted in missed work or time off, a person can claim damages related to lost wages.
  
• Future Treatments: Claimants may file claims related to past and future medical expenses, including the cost of ongoing treatment, therapy, and rehabilitation.
  
• Loss of Future Earning Capacity: If the cancer resulted in the inability to return to work or to return to work in the same capacity, a claimant may be eligible for compensation related to their loss of future earning capacity.
  
• Pain and Suffering: Most plaintiffs will be able to file for compensation related to their physical pain and emotional suffering due to the severity of the injuries.
  
• Loss of Consortium: Under certain circumstances, damages can be filed related to the loss of spousal support or companionship, particularly where the person has become incapacitated or limited by their cancer diagnosis.
  
• Funeral and Burial Costs: If the exposure caused the death of a loved one, the family members may be entitled to compensation related to their funeral and burial costs.
  
• Out-of-Pocket Expenses: Any out-of-pocket expenses related to the injuries caused by Roundup exposure are also compensable.
  
• Punitive Damages: Courts may award punitive damages in some cases to hold Monsanto (Bayer) accountable for their intentional misconduct or gross negligence and to deter similar future conduct. 

Who Qualifies to File a RoundUp Lawsuit?

In order to file a Roundup lawsuit, each person has to meet certain eligibility requirements. Our legal partners are focusing on the specific injuries listed below:

• Diagnosis of non-Hodgkin’s lymphoma: To qualify for a RoundUp lawsuit, claimants must have been diagnosed with non-Hodgkin’s lymphoma, lymphoma subtype, or a related cancer, such as B-cell lymphoma, mantle cell lymphoma 
• Exposure to RoundUp: Plaintiffs must also have had prolonged exposure to Roundup. Stronger cases include individuals who were exposed to the pesticide in occupational settings such as farming and landscaping. 
• Duration of Exposure: Must have used Roundup for a significant period of time, at least over 80 hours within the two years prior to a related cancer diagnosis. 
• Diagnosed On or After June 1, 2018: Must have been diagnosed with cancer on or after June 1, 2018, due to the statute of limitations. 
• Proof of Age and Health at Diagnosis: Pre-existing conditions may preclude you from filing. Medical records can help establish your age and health at the time of diagnosis. Special considerations are given for those aged 12 or younger at the time of exposure. 

Individuals who have lost a loved one may file a claim related to their family member’s wrongful death. An attorney can provide guidance about the eligibility requirements for this kind of lawsuit.

Prior cases and studies demonstrate a link between exposure to glyphosate (the main ingredient in RoundUp) and certain types of lymphomas, which can help support your claim. However, historically, Monsanto (Bayer) has denied allegations about the dangers of RoundUp, adding to the complexity of these lawsuits. Working with an attorney can help you navigate the legal process and receive the compensation you deserve.

What Proof Do You Need to File a RoundUp Lawsuit?

To prove a RoundUp lawsuit, you need to gather documentation that can support your claim. An attorney can assist in determining what evidence is necessary, such as your medical records, proof of exposure, witness statements, and other information. They will also help to show that Monsanto (Bayer) failed to warn consumers about the risks of glyphosate and were negligent in the design of the product. 

Prior to filing, it is important to discuss all aspects of your case with your attorney, including how your cancer diagnosis impacted your quality of life and the specific timeline of exposure. 

Evidence of RoundUp Use and Timeline of Use

• Proof of Exposure: Roundup use and duration can be proven through purchase receipts, product containers, employment records, and witness statements. Individuals in the agricultural or landscaping industry may have a stronger claim due to the extent of exposure they receive from their industry.
  
• Timeline of Use: In addition to proving exposure, you must all show the length of time you used the product and establish a connection between your exposure and the cancer. Scientific studies may help to provide a link, substantiating your claim. 

Evidence About Your Diagnosis and Treatments

• Medical Documentation: A comprehensive set of your medical records is critical to proving your health at the time of diagnosis, the type and stage of your cancer, and the treatment plan, such as chemotherapy, radiation, or surgery. These records should also help to establish a timeline between your use of RoundUp and the onset of health issues from a related condition.
  
• Death Certificate: If your loved one died as a result of their RoundUp exposure, you should provide their death certificate, as well as proof of actual or estimated funeral and burial costs, medical expenses, and other out-of-pocket losses. 

Evidence Showing Your Losses

• Proof of Economic and Non-Economic Losses: You must be able to show your damages through medical bills, proof of lost wages, and how cancer has impacted your quality of life. The more information you can provide, the stronger your claim will be. Most claimants are eligible for future damages as well, meaning the cost of ongoing treatments and any loss of earning capacity.

Testimony From You and Your Family

• Personal Statements: One of the key considerations in a RoundUp lawsuit is how your cancer affected your daily life and your relationships. Your attorney may ask you to provide a statement about how the condition has impacted your quality of life, including your close relationships.
  
• Witness Statements: Statements from friends, family members, and coworkers can help to corroborate the impact the cancer diagnosis had on your life and those relationships, as well as help to prove the extent of your Roundup use. 

9 Steps to File a RoundUp Lawsuit

In order to file a successful lawsuit, there are several steps that a person should follow. Roundup claims are unique because the time between exposure and cancer diagnosis or the discovery of a connection between the two can be extensive. Working with an experienced attorney can help to confirm eligibility and ensure all legal requirements are met prior to filing. 

These are the 9 steps for filing a RoundUp lawsuit:

1. Confirm Eligibility: The first step in a RoundUp lawsuit is confirming eligibility. 

• Proof of Diagnosis: Successful claimants will have received a cancer diagnosis of non-Hodgkin’s lymphoma or another cancer related to glyphosate exposure. 
• Proof of Exposure: Potential plaintiffs should be able to verify exposure to RoundUp through purchase receipts, usage logs, or witness testimony.
  

2. Consult a Specialized Lawyer: The lawyer you retain is critical to the outcome of your case. It is imperative to look for an attorney well-versed in toxic exposure or product liability claims, specifically those with experience in RoundUp lawsuits. Most law firms offer a free initial case evaluation to help determine whether you have a valid claim.
   
3. Gather and Prepare Necessary Documentation: Once eligibility is determined, your attorney may have you gather all necessary evidence to help substantiate your case, including your medical records that confirm your diagnosis and treatment. They will also want to verify exposure to the pesticide through purchase receipts and compile witness statements that can corroborate your use of the product.
   
4. File the Lawsuit: With the necessary documentation gathered, your attorney will file a legal complaint against the manufacturer of Roundup, Monsanto (now Bayer). They will ensure the case is filed in the appropriate courthouse and within the statute of limitations.
   
5. Discovery Phase: After the lawsuit is filed, the case will enter the discovery phase where both parties exchange and review information and evidence. During the discovery phase there may be depositions, interrogatories, and requests for additional documents. Parties may also hire experts to testify about the dangers of glyphosate and how its exposure affected your health.
   
6. Settlement Negotiations: Throughout the case, your attorney may be engaged in settlement negotiations with Bayer’s representatives. All settlement offers should be reviewed with your attorney to determine whether they cover your losses, including future medical treatments and the pain and suffering you endured as a result of your diagnosis.
   
7. Go to Trial: If a settlement cannot be reached, the matter may be set for trial. At trial, both parties present their case, and the outcome is determined by a judge or jury.
   
8. Post-Trial Monitoring: If the outcome of the trial is unfavorable, you may be able to appeal the decision. An attorney can review the appeals process and assist with the legal filing. If the judge or jury awards you damages, your lawyer will help ensure you collect your damages.
   
9. Monitor Health and Follow-Up: As the case resolves, it is important to continue to monitor your health and follow the treatment recommended by your medical team. Your lawyer will reach out with any case updates, such as post-trial follow-ups or appeals. 

What to Expect When Filing a RoundUp Lawsuit

It is important to understand that a RoundUp lawsuit can be a lengthy process. It may take several months to a year or more to resolve the case. Accepting a settlement may help to expedite the process, but should not be done until an attorney has reviewed the offer. 

Attorneys generally handle RoundUp lawsuits on a contingency fee basis, meaning there are no upfront fees. The value of the case depends on a number of factors, including the type and stage of cancer, extent of exposure to RoundUp, and your age and health at the time of your diagnosis.

What is the Deadline for Filing a RoundUp Lawsuit?

Under most circumstances, there is a one to three-year timeline from the date of the cancer diagnosis or the person’s death for filing a RoundUp lawsuit. These deadlines, however, vary by state and usually align with their personal injury or product liability statute of limitations. It is important to note that the gap between the exposure to Roundup and the onset of symptoms or date of diagnosis of a related illness (latency period) may play a significant role in the case. 

Important Timeline Considerations in RoundUp Lawsuits:

• Statute of Repose: A person may be barred from taking legal action if too much time has passed between the exposure to RoundUp and the filing of the lawsuit, regardless of the discovery date. 
• Public Awareness of Danger: Potential claimants are encouraged to seek legal counsel immediately as soon as they receive a diagnosis since the statute may begin when it became publicly known that RoundUp could be dangerous.  
• Pause Due to Mass Tort Litigation: If there is ongoing litigation such as multidistrict litigation or a class action lawsuit, the statute of limitation may be temporarily paused.
• Wrongful Death: If your loved one dies as a result of their RoundUp-related cancer, the timeline generally starts from the date of their death. 

RoundUp lawsuits are unique because of the length of time it can take to receive a cancer diagnosis. The statute of limitations generally does not start until a person is diagnosed or discovers the link between their cancer and exposure to the pesticide. An attorney can help ensure that all legal deadlines are met, including that the claim is filed within the statute of limitations.

RoundUp Settlements and Awards

RoundUp settlements are expected to range from approximately $5,000 to $250,000 or more. In June 2020, an $11 billion global settlement was reached, with payouts averaging over $150,000 per plaintiff. The settlement included a $1.25 billion reserve for future lawsuits. 

Factors that may affect a RoundUp settlement or award:

• Strength of the Evidence: The stronger the evidence, the better legal arguments that can be made, and the higher the potential value of the case.
• Diagnosis and Treatment: The type and stage of cancer, along with the extent of required medical treatment, the larger potential settlement amount, or jury award. 
• Types of Damages Sought: RoundUp claimants have the potential to seek both economic and non-economic losses. The more damages that are sought and proven, the more the case is worth.
• Duration and Intensity of Exposure: The extent of exposure may also play a role, with longer and more intense exposure lending itself to a higher potential payout, along with the ability to connect the exposure to your cancer diagnosis. 
• Legal Representation: Individuals who are represented by an attorney tend to receive higher payouts since an attorney can help prove damages and seek things like punitive damages on their behalf.

Over 40,000 claims remain outstanding. Payouts after the 2020 settlement agreement are still expected to average around $160,000. In general, the value of the case is determined based on a point system, where points are allocated for things like severity of the cancer, age and health at diagnosis, and extent of exposure to RoundUp. 

Average Settlement Amounts

Payouts in RoundUp claims have ranged between $5,000 and $250,000 or more. An $11 billion global settlement resolved nearly 100,000 lawsuits, with the average claimant receiving approximately $150,000. Bayer reserved around $1.25 billion for future lawsuits related to RoundUp exposure. 

Legal experts estimate that there are still around 40,000 claims pending and believe that valid cases may see payouts of around $160,000, depending on the strength of the case. 

What is the RoundUp Settlement Points System?

The RoundUp Settlement Points System is a way for courts to allocate settlement funds based on individual claims. Points are assigned to cases based on factors such as the type and duration of exposure, cancer type and stage, health at diagnosis, and treatment requirements.

The points system was designed to help ensure a more equitable distribution of global settlement funds. However, claimants do have the right to appeal their points allocation. Only one appeal is allowed, and the decision is final. 

Factors that can affect point allocation:

• RoundUp Exposure: The type and duration of RoundUp use may significantly impact the point allocation you receive, with more points being awarded to those with longer exposure. Also, the ability to show a direct correlation between the length of exposure and cancer diagnosis.
  
• Type and Stage of Cancer: The impact on your health may also affect the number of allocated points, particularly if you were diagnosed with non-Hodgkin’s lymphoma.
  
• Age and Health at Diagnosis: Your overall age and health may also play a role, with additional points being given to those who were younger and healthier at the time of diagnosis. Typically, it is divided into five categories to help assess the cancer’s impact on a person’s health.
  
• Treatment Requirements: The length and severity of the treatment, such as necessary surgeries, chemotherapy, radiation, and doctor appointments, may also impact your potential settlement.
  
• Other Losses: The court may also factor in other damages, such as any loss of income, pain and suffering, and out-of-pocket losses.

In a tiered system, the claims are classified based on the severity of the case and level of exposure. Higher-tier cases, which are awarded larger settlements, are generally reserved for individuals who used RoundUp daily, such as landscapers and agricultural workers. Lower-tier cases may include homeowners who did not use the pesticide as frequently or plaintiffs with cancers that have less of a direct link to RoundUp. 

Learn More About RoundUp Lawsuits From Our Legal Team

Non-Hodgkin’s lymphoma is a devastating form of blood cancer. If you have received a diagnosis of this or another form of cancer after repeated exposure to RoundUp, you may be eligible for compensation to help cover your treatments and medical bills. Our legal team can help you understand your rights and determine whether you may be eligible to file a lawsuit. Act fast, as you may only have a limited amount of time to take legal action.

FAQs